Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort.

Janzen, Donica; Bolton, James M; Leong, Christine; Kuo, I Fan; Alessi-Severini, Silvia

Janzen, Donica; Bolton, James M; Leong, Christine; Kuo, I Fan; Alessi-Severini, Silvia.

Afiliação

Janzen D; College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Bolton JM; Department of Psychiatry, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Leong C; College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Kuo IF; Department of Psychiatry, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Alessi-Severini S; College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Front Pharmacol ; 13: 879224, 2022.

Article em En | MEDLINE | ID: mdl-35662722

Palavras-chave

antipsychotic treatment; comparative effectiveness; long-acting injectable and oral antipsychotics; psychotic disorders; real-world data

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google